Ziad Issa is a Cardiology physician affiliated with St. John's Hospital. OpenAlex indexes 159 publications with 1,293 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
619 E Mason St
Suite 4p57
Springfield, IL 627011034
Telephone
217-788-0706Provider last certified this registry record 28 Dec 2021.
Clinical trials
- NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
Sponsor: Biosense Webster, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202538 payments$38,103openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year20251 payment
- Medtronic, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.7%Antiarrhythmic34.4%Dofetilide36%Amiodarone Hcl29%Flecainide Acetate29%Propafenone Hcl3%Propafenone Hcl Er3%Part D<11 patientsBeta blocker16.3%Metoprolol Succinate68%Sotalol14%Carvedilol13%Metoprolol Tartrate5%Part D<11 patients+ 4 more classes in this area
Blood & clotting
41.3%Factor Xa inhibitor39.8%Eliquis83%Xarelto17%Part D≥149 patientsDirect thrombin inhibitors0.7%Dabigatran Etexilate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pulsed Field Ablation for Persistent Atrial Fibrillation
Journal of the American College of Cardiology
2025 - Effects of Atrioventricular Optimization on Left Ventricular Reverse Remodeling With Cardiac Resynchronization Therapy: Results of the SMART-CRT Trial
Circulation Arrhythmia and Electrophysiology
2023 - Outcome of transvenous lead extraction of leads older than 20 years
Journal of Cardiovascular Electrophysiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”